Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

48.88
Delayed Data
As of 4:00pm ET
 +2.40 / +5.16%
Today’s Change
24.58
Today|||52-Week Range
60.01
+2.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues110.9M160.3M110.3M104.2M
 
 
 
 
 
Depreciation And Amortization2.3M2.3M2.4M2.4M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses91.8M116.9M93.9M103.4M
 
 
 
 
 
Research And Development83.9M101.1M82.6M83.4M
 
 
 
 
 
Total Operating Expenses94.1M119.2M96.3M105.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income16.8M41.2M14.0M-1.7M
 
 
 
 
 
Extraordinary Charge-700.0K-4.0M0.000.00
 
 
 
Interest Expense On Debt9.7M9.9M11.4M11.8M
 
 
 
 
 
Other Expenses0.0013.0K-1.1M0.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income7.4M28.8M3.5M-11.0M
 
 
 
 
 
Income Taxes0.00-2.9M0.00-222.0K
 
 
 
Net Income7.4M25.9M3.5M-11.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS121.0M121.3M122.9M124.0M
 
 
 
 
 
Shares To Calculate EPS Diluted123.4M124.0M125.0M124.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.06$0.21$0.03-$0.09
 
 
 
 
 
EPS Diluted$0.06$0.21$0.03-$0.09